International Prostate Forum

Presentations:

• 8:01 AM – 8:05 AM CST

  International Prostate Forum Introductions
  

  Chair: John Warren Davis, MD – MD Anderson Cancer Center - Dept of Urology

  Chair: Neal D. Shore, MD (he/him/his)
• 8:05 AM – 8:50 AM CST

  Challenge I: Germline Testing in Prostate Cancer — Unlocking the Codes
  

  Moderator: Isla P. Garraway, MD,PhD (she/her/hers)
• 8:06 AM – 8:20 AM CST

  Lecture: Germline Testing for Prostate Cancer in 2023 — Knowing when to Test, How to Counsel, and which Mutations Matter
  

  Speaker: Isla P. Garraway, MD,PhD (she/her/hers)
• 8:20 AM – 8:40 AM CST

  Challenge Panel: Cases in Germline Testing for Prostate Cancer
  

  Moderator: Isla P. Garraway, MD,PhD (she/her/hers)

  Panelist: Raoul S. Concepcion, MD (he/him/his) – U.S. Urology Partners

  Panelist: John Warren Davis, MD – MD Anderson Cancer Center - Dept of Urology

  Panelist: Christine O. Ibilibor, MD, MSC – University of Virginia
• 8:40 AM – 8:50 AM CST

  Follow-Up Lecture: Somatic Testing — What’s the Difference? Why Bother?
  

  Speaker: Peter Robert Carroll, MD, MPH (he/him/his) – UCSF Department of Urology
• 8:50 AM – 9:25 AM CST

  Challenge II: Alternative Local Treatments: Reality vs Hype
  

  Moderator: Art R. Rastinehad, DO – Smith Institute For Urology At Lenox Hill
• 8:51 AM – 9:05 AM CST

  Lecture: Focal Smorgasbord vs Regulator/Guidelines Approvals
  

  Speaker: Art R. Rastinehad, DO – Smith Institute For Urology At Lenox Hill
• 9:05 AM – 9:25 AM CST

  Challenge Panel: Alternative Local Treatments
  

  Moderator: Art R. Rastinehad, DO

  Panelist: Mark Emberton, MD – UCL

  Panelist: Rafael Sanchez-Salas, MD (he/him/his) – McGill University

  Panelist: Derya Tilki, MD – Martini-Klinik Prostate Cancer Center
• 9:25 AM – 10:00 AM CST

  Challenge III: Screening and Early Disease Management in Septuagenarians
  

  Moderator: Samuel L. Washington, III, MD
• 9:26 AM – 9:40 AM CST

  Lecture: How to Select Appropriate Candidates in their 70’s for PSA Screening and Curative Treatment vs Observation Strategies
  

  Speaker: Samuel L. Washington, III, MD
• 9:40 AM – 10:00 AM CST

  Challenge Panel: Screening and Early Disease Management in Septuagenarians
  

  Moderator: Samuel L. Washington, III, MD

  Panelist: Rafael Ferreira Coelho, MD, PhD – University of Sao Paulo School of Medicine

  Panelist: Alan McNeill, MD (he/him/his) – Western General Hospital

  Panelist: Arturo Mendoza-Vald�s, MD (he/him/his) – Hospital Medica Sur
• 10:00 AM – 10:35 AM CST

  Challenge IV: Guideline of Guidelines in Prostate Cancer
  

  Moderator: Stephen A. Boorjian, MD – Mayo Clinic, Dept. of Urology
• 10:01 AM – 10:15 AM CST

  Lecture: Prostate Cancer Guidelines — Where I see Progress and Help with my Practice
  

  Speaker: Stephen A. Boorjian, MD – Mayo Clinic, Dept. of Urology
• 10:15 AM – 10:35 AM CST

  Challenge Panel: Screening and Treatment Guideline Updates — When do they Help, and When is it Hard to Comply?
  

  Moderator: Stephen A. Boorjian, MD – Mayo Clinic, Dept. of Urology

  Panelist: Daniel Eberli, MD, PHD – University Hospital Zurich, Urology

  Panelist: Badar Munir Mian, MD – Albany Medical Center

  Panelist: Kelvin A. Moses, MD, PHD – Vanderbilt University Dept of Urology

  Panelist: Bernardo Maria Rocco, MD
• 10:35 AM – 11:10 AM CST

  Challenge V: Next Generation Imaging with the RADAR Group
  

  Moderator: E. David Crawford, MD
• 10:36 AM – 10:50 AM CST

  Lecture: Next Generation Imaging Updates from the RADAR Group
  

  Speaker: E. David Crawford, MD
• 10:50 AM – 11:10 AM CST

  Challenge Panel: Cases for Imaging Updates from RADAR, SNMM, EANM
  

  Moderator: E. David Crawford, MD

  Panelist: Sung Kyu Hong, MD (he/him/his) – Seoul National University Bundang Hospital

  Panelist: Christopher J. Kane, MD

  Panelist: Phillip Koo, MD

  Panelist: Nathan Lawrentschuk, PHD,MBBS – University of Melbourne
• 11:10 AM – 11:45 AM CST

  Challenge VI: Oligometastatic Disease: Local and Site Directed
  

  Moderator: Robert Jeffrey Karnes, MD
• 11:11 AM – 11:25 AM CST

  Lecture: Oligometastatic Disease—Who/Why for Directed Therapy
  

  Speaker: R. Jeffrey Karnes, MD
• 11:25 AM – 11:45 AM CST

  Challenge Panel: Cases in Oligometastatic Disease
  

  Moderator: R. Jeffrey Karnes, MD

  Panelist: Alberto Briganti, MD

  Panelist: Michael A. Gorin, MD

  Panelist: Daniel Spratt, MD – UH Seidman Cancer Center/Case Western

  Panelist: George Niklaus Thalmann, MD (he/him/his) – University of Berne
• 11:45 AM – 12:45 PM CST

  Challenge VII: Updates in Advanced Prostate Cancer
  

  Moderator: Neal D. Shore, MD (he/him/his)
• 11:46 AM – 11:55 AM CST

  First Update: Managing our Metastatic Hormone Sensitive Prostate Cancer Patients: Are We There Yet?
  

  Speaker: Maha Hussain, MD, FACP, FASCO (she/her/hers)
• 11:55 AM – 12:05 PM CST

  Panel Time: Metastatic Castrate Sensitive Prostate Cancer
  

  Panelist: Thomas Boike, MD (he/him/his)

  Panelist: Maha Hussain, MD, FACP, FASCO (she/her/hers)

  Panelist: Fred Saad, MD,FRCSC
• 12:05 PM – 12:15 PM CST

  Second Update: Is Combination Therapy the New Standard of Care for Metastatic Castrate Resistant Prostate Cancer Patients?
  

  Speaker: Fred Saad, MD,FRCSC
• 12:15 PM – 12:25 PM CST

  Panel Time: Metastatic Castrate Resistant Prostate Cancer
  

  Panelist: Thomas Boike, MD (he/him/his)

  Panelist: Maha Hussain, MD, FACP, FASCO (she/her/hers)

  Panelist: Fred Saad, MD,FRCSC
• 12:25 PM – 12:35 PM CST

  Third Update: What is the Urologists Role for Theranostics?
  

  Speaker: Thomas Boike, MD (he/him/his)
• 12:35 PM – 12:45 PM CST

  Panel Time: Cases in Prostate Cancer Theranostics
  

  Panelist: Thomas Boike, MD (he/him/his)

  Panelist: Maha Hussain, MD, FACP, FASCO (she/her/hers)

  Panelist: Fred Saad, MD,FRCSC
• 12:45 PM – 1:00 PM CST

  Debrief Time